tiprankstipranks
TipRanksTop Financial ExpertsInsidersFaheem Hasnain

Faheem Hasnain Insider Profile

25 Followers
Faheem Hasnain, President & CEO, Director at Gossamer Bio, holds 6.25M shares in Gossamer Bio (Ticker: GOSS), holds 23.98K shares in Kura Oncology (Ticker: KURA), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX).
See the Hottest Stocks Based on Insider Trading >
tipranks
Faheem Hasnain

Faheem Hasnain
Gossamer Bio (GOSS)
President & CEO, Director

Ranked #95,958 out of 109,030 Corporate Insiders

Profitable Transactions

36%
4 out of 11 Profitable Transactions

Average Return

-21.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$73M
91.50%
7.55%
0.46%
0.37%
0.12% Others
A breakdown of Faheem Hasnain's holdings
See the Top Stocks by Insiders

Insider Roles

Gossamer Bio
(GOSS)
President & CEO, Director
Biogen
(BIIB)
EVP, Oncology/Rheumatology SBU
Nuvation Bio
(NUVB)
Director
Kura Oncology
(KURA)
Director
+1 other positions
Roles that Faheem Hasnain holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Gossamer Bio
(GOSS)
Rating:Informative Buy
Date:Jun 24, 2024 - Jun 24, 2025
Return:+67.00%
The most profitable trade made by Faheem Hasnain
See the Latest Stocks Traded by Insiders

Faheem Hasnain's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GOSS
Gossamer Bio
Jan 05, 2026
President & CEO, Director
Uninformative Buy
―
$67.02M
MRTX
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
NUVB
Nuvation Bio
Feb 26, 2021
Director
Uninformative Buy
550.00K
$333.85K
IMUX
Immunic
Sep 17, 2018
Director
Informative Sell
76.30K
$91.36K
KURA
Kura Oncology
Dec 10, 2025
Director
Uninformative Buy
31.20K
$273.17K
FBRX
Forte Biosciences
Jun 03, 2019
―
Informative Buy
200.23K
$18.93M
RCPT
Receptos
Aug 27, 2015
―
Uninformative Sell
―
$0.00
BIIB
Biogen
―
EVP, Oncology/Rheumatology SBU
―
$5.53M
PDLI
PDL BioPharma
―
―
―
$308.75K
SOMX
Somaxon Pharmaceuticals
Sep 21, 2010
―
Uninformative Buy
―
―
~AMBI
Ambit
―
―
―
―
List of latest transactions for each holding click on a transaction to see Faheem Hasnain's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Faheem Hasnain insider profile FAQ

What is the percentage of profitable transactions made by Faheem Hasnain?
The percentage of profitable transactions made by Faheem Hasnain is 36%.
    What is the average return per transaction made by Faheem Hasnain?
    The average return per transaction made by Faheem Hasnain is -21.90%.
      What stocks does Faheem Hasnain hold?
      Faheem Hasnain holds: GOSS, MRTX, NUVB, IMUX, KURA, FBRX, RCPT, BIIB, PDLI, SOMX, ~AMBI stocks.
        What was Faheem Hasnain’s latest transaction?
        Faheem Hasnain latest transaction was an Uninformative Buy of ―.
          What was Faheem Hasnain's most profitable transaction?
          Faheem Hasnain’s most profitable transaction was an Informative Buy of GOSS stock on June 24, 2024. The return on the trade was 67.00%.
            What is Faheem Hasnain's role in Gossamer Bio?
            Faheem Hasnain's role in Gossamer Bio is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.